Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
386. |
ECCT/16/06/02 | A5263: A Randomized Comparison of Three Regimens of Chemotherapy with Compatible Antiretroviral Therapy for Treatment of Advanced AIDS-KS in Resource-Limited Settings A Randomized Comparison of Three Regimens of Chemotherapy with Compatible Antiretroviral Therapy for Treatment of Advanced AIDS-KS in Resource-Limited Settings |
Principal Investigator(s) 1. Vincent Oliver Otieno Site(s) in Kenya 1. Kisumu CRS (Kisumu county) |
View |
387. |
ECCT/24/06/06 | EDE Scanner Study A non-interventional clinical validation study of the Exponential Deep Examination (EDE) scanner in the detection of human immunodeficiency virus (HIV), tuberculosis (TB) and malaria. |
Principal Investigator(s) 1. Bernhards Ogutu 2. Lucas Tina 3. VIDELIS NDUBA Site(s) in Kenya 1. VICTORIA BIOMEDICAL RESEARCH INSTITUTE (Kisumu county) 2. KEMRI/CRDR Siaya Clinical Trials Annex (Siaya county) 3. Ahero Clinical Trials Unit (Kisumu county) |
View |
388. |
ECCT/16/07/01 | VAC52150EBL4001 A Multi-country, prospective, Clinical Safety Study of Subjects Exposed to the Candidate Ebola Vaccines AD26.ZEBOV and or/ MVA-BN-Filo |
Principal Investigator(s) 1. Omu Anzala Site(s) in Kenya 1. KAVI-Institute of Clinical Research (Nairobi City county) 2. Kenya medical Research Institute/Walter Reed Project Kombewa (Kisumu county) 3. Kenya medical Research Institute/Walter Reed Project Kombewa (Kericho county) |
View |
389. |
ECCT/20/08/01 | CorNeat EverPatch The CorNeat EverPatch – A First-In-Human Clinical Study for Demonstrating the Safety of a Synthetic Tissue Substitute for Concealment of Artificial Implants and Glaucoma Tube Shunts |
Principal Investigator(s) 1. Lily Adhiambo Nyamai Site(s) in Kenya 1. Lions SightFirst Hospital (Nairobi City county) 2. Kenyatta National Hospital (Nairobi City county) 3. Kwale Eye Centre (Kwale county) |
View |
390. |
ECCT/21/06/05 | VAT00008 A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of ageand older |
Principal Investigator(s) 1. Nelly Rwamba Mugo Site(s) in Kenya KEMRI-CCR-PHRD THIKA PROJECT |
View |